160 related articles for article (PubMed ID: 28467996)
21. Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.
Brick KE; Weaver CH; Lohse CM; Pittelkow MR; Lehman JS; Camilleri MJ; Al-Hashimi M; Wieland CN
J Am Acad Dermatol; 2014 Jul; 71(1):92-9. PubMed ID: 24704091
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of pemphigoid following scabies: a population-based matched-cohort study.
Chung SD; Lin HC; Wang KH
J Eur Acad Dermatol Venereol; 2014 May; 28(5):558-64. PubMed ID: 23506522
[TBL] [Abstract][Full Text] [Related]
23. Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
Chen CL; Wu CY; Lyu YS; Chou YJ; Chang YT; Wu CY
J Dermatol; 2022 Aug; 49(8):753-761. PubMed ID: 35491650
[TBL] [Abstract][Full Text] [Related]
24. Mortality of patients with bullous pemphigoid in Korea.
Lee JH; Kim SC
J Am Acad Dermatol; 2014 Oct; 71(4):676-83. PubMed ID: 24930586
[TBL] [Abstract][Full Text] [Related]
25. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
[TBL] [Abstract][Full Text] [Related]
26. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.
Gudi VS; White MI; Cruickshank N; Herriot R; Edwards SL; Nimmo F; Ormerod AD
Br J Dermatol; 2005 Aug; 153(2):424-7. PubMed ID: 16086760
[TBL] [Abstract][Full Text] [Related]
27. Association between inflammatory bowel disease and bullous pemphigoid: a population-based case-control study.
Chen YJ; Juan CK; Chang YT; Wu CY; Ho HJ; Tseng HC
Sci Rep; 2020 Jul; 10(1):12727. PubMed ID: 32728039
[TBL] [Abstract][Full Text] [Related]
28. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
29. Association between sodium-glucose co-transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a nationwide population-based cohort study.
Ma SH; Wu CY; Lyu YS; Chou YJ; Chang YT; Wu CY
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1318-1324. PubMed ID: 35344615
[TBL] [Abstract][Full Text] [Related]
30. Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study.
Chang TH; Wu CY; Chang YT; Lyu YS; Wu CY
Acta Derm Venereol; 2023 Jun; 103():adv5329. PubMed ID: 37272362
[TBL] [Abstract][Full Text] [Related]
31. Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.
Försti AK; Jokelainen J; Ansakorpi H; Seppänen A; Majamaa K; Timonen M; Tasanen K
Sci Rep; 2016 Nov; 6():37125. PubMed ID: 27845416
[TBL] [Abstract][Full Text] [Related]
32. Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study.
Huang WS; Tsai CH; Lin CL; Sung FC; Chang YJ; Kao CH
Sleep Med; 2013 Dec; 14(12):1341-7. PubMed ID: 24211072
[TBL] [Abstract][Full Text] [Related]
33. Risk of solid malignancies in bullous pemphigoid: A large-scale population-based cohort study.
Kridin K; Hammers CM; Ludwig RJ; Cohen AD
J Dermatol; 2021 Mar; 48(3):317-323. PubMed ID: 33368562
[TBL] [Abstract][Full Text] [Related]
34. Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
[TBL] [Abstract][Full Text] [Related]
35. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital.
Försti AK; Jokelainen J; Timonen M; Tasanen K
Br J Dermatol; 2014 Nov; 171(5):1223-6. PubMed ID: 24934834
[TBL] [Abstract][Full Text] [Related]
36. Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients.
Daneshpazhooh M; Khorassani J; Balighi K; Ghandi N; Mahmoudi H; Tohidinik H; Hamzelou S; Chams-Davatchi C
Indian J Dermatol Venereol Leprol; 2017; 83(2):195-199. PubMed ID: 27679408
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.
Rzany B; Partscht K; Jung M; Kippes W; Mecking D; Baima B; Prudlo C; Pawelczyk B; Messmer EM; Schuhmann M; Sinkgraven R; Büchner L; Büdinger L; Pfeiffer C; Sticherling M; Hertl M; Kaiser HW; Meurer M; Zillikens D; Messer G
Arch Dermatol; 2002 Jul; 138(7):903-8. PubMed ID: 12071817
[TBL] [Abstract][Full Text] [Related]
38. Incidence and mortality of bullous pemphigoid in France.
Joly P; Baricault S; Sparsa A; Bernard P; Bédane C; Duvert-Lehembre S; Courville P; Bravard P; Rémond B; Doffoel-Hantz V; Bénichou J
J Invest Dermatol; 2012 Aug; 132(8):1998-2004. PubMed ID: 22418872
[TBL] [Abstract][Full Text] [Related]
39. Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid.
Shen WC; Chiang HY; Chen PS; Lin YT; Kuo CC; Wu PY
JAMA Dermatol; 2022 Feb; 158(2):167-175. PubMed ID: 34964804
[TBL] [Abstract][Full Text] [Related]
40. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study.
Langan SM; Groves RW; West J
J Invest Dermatol; 2011 Mar; 131(3):631-6. PubMed ID: 21085189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
